Correlation of Right Heart Catheterization (RHC) Parameters and Functional Tests after 16 Weeks of Bosentan-Based Therapy in Patients with Pulmonary Arterial Hypertension (PAH): The COMPASS-3 Study

被引：0
|
作者：
Torres, F. [1 ]
Murali, S. [2 ]
Soto, F. J. [3 ]
Gupta, H. [4 ]
Park, M. H. [5 ]
Frey, N. [6 ]
Benza, R. L. [2 ]
机构：
[1] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[2] Allegheny Gen Hosp, Pittsburgh, PA 15212 USA
[3] Prevea Hlth, Sheboygan, WI USA
[4] Univ Alabama, Birmingham, AL USA
[5] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
[6] Actelion Pharmaceut US Inc, San Francisco, CA USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2010年 / 29卷 / 02期
关键词：
D O I：
10.1016/j.healun.2009.11.069
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
61
引用
下载
收藏
页码：S26 / S26
页数：1
相关论文
共 8 条
  • [1] Bosentan-based, treat-to-target therapy in patients with pulmonary arterial hypertension: results from the COMPASS-3 study
    Benza, Raymond L.
    Raina, Amresh
    Gupta, Himanshu
    Murali, Srinivas
    Burden, Annie
    Zastrow, Michael S.
    Park, Myung H.
    Simon, Marc A.
    PULMONARY CIRCULATION, 2018, 8 (01)
  • [2] Differences Between Idiopathic Pulmonary Arterial Hypertension and Connective Tissue Disease-Associated Pulmonary Arterial Hypertension After 16 Weeks of Bosentan Monotherapy: The COMPASS-3 Study
    Murali, S.
    Gupta, H.
    Soto, F.
    Park, M. H.
    Torres, F.
    Frey, N.
    Benza, R. L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [3] Goal-directed combination therapy in pulmonary arterial hypertension (PAH): Study design of COMPASS-3
    Torres, Fernando
    Gupta, Himanshu
    Murali, Srinivas
    Park, Myung H.
    Soto, Francisco J.
    McQueen, Chad
    Benza, Raymond L.
    CHEST, 2007, 132 (04) : 633S - 633S
  • [4] Effect of 16 Weeks of Bosentan-Based Therapy on Cardiac MRI (cMRI) Derived Ventricular Function, 6-Minute Walk Test Distance (6MWD) and Borg Dyspnea Index (BDI) in Patients with Pulmonary Arterial Hypertension (PAH): Results from the COMPASS-3 Study
    Murali, S.
    Lloyd, S. G.
    Gupta, H.
    Soto, F. J.
    Park, M. H.
    Torres, F.
    Frey, N.
    Benza, R. L.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (02): : S97 - S97
  • [5] TRANSTHORACIC ECHOCARDIOGRAM (ECHO) AND RIGHT HEART CATHETERIZATION (RHC) AS DISEASE MANAGEMENT TOOLS FOR PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH) IN US CLINICAL PRACTICE
    Chakinala, Murali
    Frantz, Robert
    Frost, Adaani
    Lancaster, Lisa
    Nathan, Steven
    Oudiz, Ronald
    Dee, Anne
    Narayan, Veena
    Panjabi, Sumeet
    Wick, Nicole
    Farber, Harrison
    CHEST, 2021, 160 (04) : 2331A - 2333A
  • [6] Therapy-Related Shifts in NT-proBNP Correlate with Changes in 6MWD and cMRI Parameters in Bosentan-Treated Patients with PAH: The COMPASS-3 Study
    Park, M. H.
    Murali, S.
    Soto, F. J.
    Torres, F.
    Gupta, H.
    Frey, N.
    Benza, R. L.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (02): : S46 - S46
  • [7] Incidence of right heart catheterization in patients initiated on pulmonary arterial hypertension therapies: A population-based study
    Duarte, Alexander G.
    Lin, Yu Li
    Sharma, Gulshan
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (02): : 220 - 226
  • [8] Heart structural and functional changes by Cardiac Magnetic Resonance (CMR) after targeted medical therapy in patients with Pulmonary Arterial Hypertension (PAH)
    Bachetti, C.
    Palazzini, M.
    Leci, E.
    Conficoni, E.
    Gotti, E.
    Mazzanti, G.
    Sgro, F.
    Manes, A.
    Branzi, A.
    Galie, N.
    EUROPEAN HEART JOURNAL, 2010, 31 : 752 - 752
1